What does Travoprost Intracameral (Idose Tr) do in plain English—and how does it work inside your body?
Travoprost Intracameral is an FDA-regulated Prostaglandin Analog (RxNorm RxCUI RXN-25357100-3079). Mechanistically, Biochemical activity of Travoprost Intracameral reflects prostaglandin analog pathway engagement after intracameral-route dosing (75 ug/1 Implant, manufactured/labeled by Glaukos Corporation, NDC 25357-100), supporting titratable maintenance pharmacotherapy. [1][2].
When your doctor writes a prescription for Travoprost Intracameral (RxNorm RxCUI RXN-25357100-3079, also dispensed under brand names including Idose Tr), the goal is to target the root physiological pathway driving your condition rather than just masking surface symptoms [1]. According to the official FDA DailyMed package insert, Biochemical activity of Travoprost Intracameral reflects prostaglandin analog pathway engagement after intracameral-route dosing (75 ug/1 Implant, manufactured/labeled by Glaukos Corporation, NDC 25357-100), supporting titratable maintenance pharmacotherapy. [2].
Across real-world patient logs on dotMD (81% positive worth-it rating), patients do best when they understand both what the medication is doing on day 1 and how long it takes to reach steady-state protection [3].
Check the imprint code on your Travoprost Intracameral tablet bottle and confirm with your pharmacist that it matches your prescribed strength (75 ug/1 Implant, Stepwise Travoprost Intracameral titration guided by clinical response and eGFR).